Table 5.
Post-BMT clinical status
| Pt. no. | Disease | Donor chimerism day +60 % donor | GVHD | Disease relapse | F/U time | |
|---|---|---|---|---|---|---|
|
| ||||||
| Unsorted PBL | CD3+ PBL | |||||
|
| ||||||
| 1 | AML | 100 | 100 | No | No | 3.9 Years |
| 2 | AML | 94 | NT | No | 3 Mos. | Died: 17 mos. |
| 3 | AML | >95 | 100 | No | 5 Mos. | Died: 7 mos. |
| 4 | MDS | 100 | 100 | Grade 1 skin | No | Died: 2.3 years viral pneumonia |
| 5 | MDS | 100 | 100 | Grade 1 skin | 12 Mos. | Died: 18 mos. |
| 6 | MDS | 100 | 100 | No | 16 mos. | Died: 20 mos. |
| 8 | T-cell lymphoma | 100 | 100 | Grade 1 skin | No | Died: 1.1 years hepatitis C |
| 9 | Hodgkin's lymphoma | >95 | <5 | No | No | 2.1 Years |
| 10 | AML | >95 | 100 | No | 4 Mos. | Died |
| 11 | MDS | >95 | 100 | No | No | Died non-transplant related |
| 12 | SS | 94 | <5 | No | No | 1.5 Years |
| 13 | AML | >95 | 100 | No | 4 Mos. | Died: 4.3 mos. |
| 14 | AML | 100 | <5 | No | No | 1 Year |
| 15 | AML | 100 | 100 | Grade 1 skin | 4 Mos. | Died: 4 mos. |
Abbreviations: MDS=myelodysplastic syndrome; SS=sickle cell disease; NT=not tested.